Trial Outcomes & Findings for A Cluster-randomized Cross-over Trial Evaluating the Comparative Effectiveness of Three Skin Antiseptic Interventions (NCT NCT01216761)
NCT ID: NCT01216761
Last Updated: 2017-01-11
Results Overview
A culture set was considered contaminated if it yielded growth of typical skin contaminants including aerobic gram positive rods, Lactobacillus sp, Propionibacterium acnes, Micrococcus sp, Bacillus sp (not B. anthracis or B. cereus), coag negative Staphylococcus, Neisseria sp (not N. meningitides or N. gonorrhoeae), or gamma-hemolytic streptococci (not Enterococcus sp) from only 1 of 2 or more blood culture sets obtained from different sites.
COMPLETED
NA
3879 participants
5 days
2017-01-11
Participant Flow
Please note: it is possible for a single patient to have multiple blood culture sets obtained throughout the study. Therefore, number of blood culture sets will differ from the number of unique patients. Also, cross-over assignment occurred at the hospital floor level - not the individual subject level.
Participant milestones
| Measure |
CHG Then PI Then IT
2% chlorhexidine gluconate/70% isopropyl alcohol packaged in a single 1.5 ml Frepp applicators (Enturia, Leewood KS) -- CHG
10% povidone iodine aqueous solution packaged in a single 0.67 Sepp applicator (Enturia, Leewood KS) -- PI
Iodine tincture (2% iodine and 2% sodium iodide diluted in 50% ethanol) packaged in a single 0.67 mL Sepp applicator (Enturia, Leewood KS) -- IT
|
IT Then CHG Then PI
Iodine tincture (2% iodine and 2% sodium iodide diluted in 50% ethanol) packaged in a single 0.67 mL Sepp applicator (Enturia, Leewood KS) -- IT
2% chlorhexidine gluconate/70% isopropyl alcohol packaged in a single 1.5 ml Frepp applicators (Enturia, Leewood KS) -- CHG
10% povidone iodine aqueous solution packaged in a single 0.67 Sepp applicator (Enturia, Leewood KS) -- PI
|
PI Then IT Then CHG
10% povidone iodine aqueous solution packaged in a single 0.67 Sepp applicator (Enturia, Leewood KS) -- PI
Iodine tincture (2% iodine and 2% sodium iodide diluted in 50% ethanol) packaged in a single 0.67 mL Sepp applicator (Enturia, Leewood KS) -- IT
2% chlorhexidine gluconate/70% isopropyl alcohol packaged in a single 1.5 ml Frepp applicators (Enturia, Leewood KS) -- CHG
|
|---|---|---|---|
|
Overall Study
STARTED
|
1421
|
1410
|
1379
|
|
Overall Study
COMPLETED
|
1421
|
1410
|
1379
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
A Cluster-randomized Cross-over Trial Evaluating the Comparative Effectiveness of Three Skin Antiseptic Interventions
Baseline characteristics by cohort
| Measure |
Total Population
n=3879 Participants
|
|---|---|
|
Age, Continuous
|
56.8 years
STANDARD_DEVIATION 17.9 • n=5 Participants
|
|
Sex/Gender, Customized
Male
|
0 participants
n=5 Participants
|
|
Sex/Gender, Customized
Female
|
0 participants
n=5 Participants
|
|
Sex/Gender, Customized
Unknown
|
3879 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 5 daysPopulation: Intention to treat analyses. Please note: it is possible for a single patient to have multiple blood culture sets obtained throughout the study. Therefore, number of blood culture sets will differ from the number of unique patients.
A culture set was considered contaminated if it yielded growth of typical skin contaminants including aerobic gram positive rods, Lactobacillus sp, Propionibacterium acnes, Micrococcus sp, Bacillus sp (not B. anthracis or B. cereus), coag negative Staphylococcus, Neisseria sp (not N. meningitides or N. gonorrhoeae), or gamma-hemolytic streptococci (not Enterococcus sp) from only 1 of 2 or more blood culture sets obtained from different sites.
Outcome measures
| Measure |
Chlorhexidine Gluconate (CHG_
n=4388 Blood culture sets
2% chlorhexidine gluconate/70% isopropyl alcohol packaged in a single 1.5 ml Frepp applicators (Enturia, Leewood KS) -- CHG
|
Iodine Tincture (IT)
n=4230 Blood culture sets
Iodine tincture (2% iodine and 2% sodium iodide diluted in 50% ethanol) packaged in a single 0.67 mL Sepp applicator (Enturia, Leewood KS) -- IT
|
Povidone Iodine (PI)
n=4286 Blood culture sets
10% povidone iodine aqueous solution packaged in a single 0.67 Sepp applicator (Enturia, Leewood KS) -- PI
|
|---|---|---|---|
|
Blood Culture Contamination
|
41 blood culture sets
|
32 blood culture sets
|
25 blood culture sets
|
Adverse Events
CHG Then PI Then IT
IT Then CHG Then PI
PI Then IT Then CHG
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Laraine Washer, MD
University of Michigan Health System
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place